FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> FDA | BLA | Acambis

SPOTLIGHT: Acambis completes vaccine BLA

Tools

Acambis has completed its BLA to the FDA for its experimental smallpox vaccine, ACAM2000. The drug was given fast-track status in late 2004. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about FDA   BLA   Acambis